The Board of Directors of Nanjing Vazyme Biotech Co., Ltd. has authorized a buyback plan on August 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.95 CNY | -0.22% | -5.01% | -28.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.33% | 1.26B | |
+38.59% | 727B | |
+29.91% | 592B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+12.75% | 238B | |
+7.01% | 204B | |
-5.77% | 203B | |
-1.70% | 160B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.